Key facts
- This page summarizes Steven M. Fruchtman's Form 4 filing for Onconova Therapeutics, Inc. (TRAW).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 15 Mar 2024, 17:36.
Steven M. Fruchtman - 13 Mar 2024 Form 4 Insider Report for Onconova Therapeutics, Inc. (TRAW)
- Reporting relationship
- PRESIDENT, CHIEF EXECUTIVE OFF, Director
- Issuer ticker
- TRAW
- Reported as of
- 13 Mar 2024
- Net transaction value
- -$7,854
- SEC form
- 4
- Accepted by SEC
- 15 Mar 2024, 17:36:28 UTC
- Prior SEC filing
- 09 Feb 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Mark Guerin, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Steven M. Fruchtman filed Form 4 for Onconova Therapeutics, Inc. (TRAW) on 15 Mar 2024.
Change
- Previous filing in this sequence was filed on 09 Feb 2024.
- Current net transaction value: -$7,854.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ONTX
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +23,111
- Change %
- +38%
- Price
- Shares after
- 83,519
- Date
- 13 Mar 2024
- Ownership
- Direct
- Footnotes
- F1
ONTX
transaction
Common Stock
Tax liability
- Transaction value
- $7,854
- Shares
- -8,727
- Change %
- -10%
- Price
- $0.9000
- Shares after
- 74,792
- Date
- 14 Mar 2024
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ONTX
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -23,111
- Change %
- -33%
- Price
- $0.000000
- Shares after
- 46,222
- Date
- 13 Mar 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 23,111
- Exercise price
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Restricted stock units convert into common stock on a one-for-one basis.
Footnote F2
On March 13, 2023 the reporting person was granted 69,333 restricted stock units which vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34% on the third anniversary.